Nitrate tolerance from a biochemical point of view

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Biochemistry

Background:

• Nitrate vasodilators are widely used for cardiovascular conditions.
• Tolerance to nitrate vasodilators is a recognized clinical phenomenon.
• The precise mechanisms underlying nitrate tolerance remain incompletely understood.

Purpose of the Study:

• To elucidate the underlying mechanisms of tolerance to nitrate vasodilators.
• To investigate the role of cyclic guanosine-3',5'-monophosphate (cGMP) metabolism in nitrate tolerance.
• To explore potential alterations in drug metabolism within the vascular wall.

Main Methods:

• Review of existing literature on nitrate tolerance.
• Analysis of studies investigating cGMP production and degradation pathways.
• Examination of evidence regarding organic nitroester metabolism in tolerant tissues.

Main Results:

• Tolerance to nitrate vasodilators appears to be a general property of this drug class.
• Reduced distribution of the drug to the vascular wall may contribute to tolerance.
• Impaired cGMP production and enhanced cGMP degradation are observed in tolerant tissues.
• Potential alterations in the degradation of organic nitroesters and production of mediating nitrosothiols were noted.

Conclusions:

• Nitrate vasodilator tolerance involves complex mechanisms affecting drug delivery and intracellular signaling.
• Dysregulation of cGMP pathways, including guanylate cyclase and phosphodiesterase activity, is implicated.
• Further research is needed to fully clarify the role of drug metabolism and intermediate signaling molecules in tolerance development.